glp-1 murfreesboro tn Med Spa & Wellness Center in Radiant Health & Wellness |
Description
A Functional Medicine Deep Dive Beyond the Hype Dr
Importantly, never reduce or stop insulin abruptly when starting GLP-1 therapy, as this carries a risk of diabetic ketoacidosis
For peptides, even minor formulation changes (buffer pH, solvent ratios) can alter solubility and aggregate formation, so front-end planning is crucial
Additionally, the phase 2 MOMENTUM clinical trial of pemvidutide (a dual GLP-1/GCG agonist) showed that only 21.9% of WL was attributable to reductions in lean mass at 48 weeks (overall WL 10.315.6% across doses) [64]
